Clinical Research Directory
Browse clinical research sites, groups, and studies.
Iatrogenic Atrial Septal Defect Gradient for Intraprocedural Success After M-teer
Sponsor: Hippocration General Hospital
Summary
Transcatheter mitral edge-to-edge repair (M-TEER) has become an established minimally invasive therapy for patients with severe mitral regurgitation (MR) who are at high or prohibitive surgical risk. However, accurate quantification of residual MR after M-TEER remains challenging. In this direction, the hemodynamic significance of the post-procedural iatrogenic atrial septal defect (iASD) gradient is unknown. The objective of this study is to assess the relationship between the post-procedural iASD pressure gradient and the severity of residual MR with intraprocedural echocardiographic and hemodynamic parameters.
Official title: Iatrogenic ASD Gradient as a Marker of Residual Mitral Regurgitation Severity After M-TEER Procedure
Key Details
Gender
All
Age Range
40 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-09-09
Completion Date
2028-06-10
Last Updated
2026-09-01
Healthy Volunteers
No
Conditions
Interventions
M-TEER
Hemodynamic and echocardiographic assessment of M-TEER procedural success
Locations (1)
First Cardiology Department, Hippokration General Hospital
Athens, Greece